<DOC>
	<DOCNO>NCT01578421</DOCNO>
	<brief_summary>The purpose study compare clearance removal rate phosphate , ß2-microglobulin ( ß2-m ) leptin albumin loss different dialyser membrane post-dilution online hemodiafiltration .</brief_summary>
	<brief_title>Investigation Middle Size Molecule Elimination Characteristics FXCorDiax 100 Relation FX 100 Polyflux 210 H Dialyser</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>hemodialysis patient 18 year older treat post dilution online Hemodiafiltration ( HDF ) least one month reach dialysis dose ( Kt/V ) least 1.2 last two monthly check stable anticoagulation anemia management whose hemoglobin 10.5 13.0 g/dl clinically stable base judgment nephrologist regular thrice weekly HDF schedule , e.g . MondayWednesdayFriday TuesdayThursdaySaturday , good vascular access ( fistula graft ) enable easy insertion needle suitable effective blood flow ( &gt; 300 ml/min ) able understand nature requirement clinical investigation give write informed consent Patients active Hepatitis B , Hepatitis C HIV infection severely malnourish judged principal investigator know suspect allergy trial product relate product central venous catheter base vascular access abuse nonlegal drug alcohol currently active malignant disease female childbearing age without effective measure contraception , pregnant breastfeeding participate simultaneously another clinical investigation participate othe clinical investigation last month uncooperative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>